Clinical Trial Update: Study of Pazopanib and Vorinostat in Patients With Advanced Malignancies [Phase 1]

View source ↗

Summary

Phase 1 study at MD Anderson evaluating the combination of pazopanib and vorinostat in patients with advanced malignancies has completed, focusing on safety and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Pazopanib (Votrient) (Pazopanib)
• Vorinostat (Zolinza) (vorinostat)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Advanced Cancer | Phase 1 | Status: COMPLETED